Annovis Bio Inc (ANVS)
12.74
+0.86
(+7.24%)
USD |
NYSE |
Apr 24, 16:00
12.59
-0.15
(-1.18%)
Pre-Market: 20:00
Annovis Bio Total Liabilities (Quarterly): 17.96M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.96M |
| September 30, 2023 | 3.565M |
| June 30, 2023 | 2.074M |
| March 31, 2023 | 5.411M |
| December 31, 2022 | 7.698M |
| September 30, 2022 | 2.526M |
| June 30, 2022 | 1.299M |
| March 31, 2022 | 1.256M |
| December 31, 2021 | 1.506M |
| September 30, 2021 | 1.121M |
| June 30, 2021 | 0.8841M |
| Date | Value |
|---|---|
| March 31, 2021 | 1.597M |
| December 31, 2020 | 0.5784M |
| September 30, 2020 | 0.2811M |
| June 30, 2020 | 0.7029M |
| March 31, 2020 | 0.7493M |
| December 31, 2019 | 9.694M |
| September 30, 2019 | 8.755M |
| June 30, 2019 | 8.421M |
| March 31, 2019 | 8.207M |
| December 31, 2018 | 7.645M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2811M
Minimum
Sep 2020
17.96M
Maximum
Dec 2023
4.004M
Average
1.597M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 34.39B |
| FibroGen Inc | 585.73M |
| Cerus Corp | 144.30M |
| OPKO Health Inc | 622.48M |
| Stereotaxis Inc | 19.99M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.21M |
| Shareholders Equity (Quarterly) | -7.751M |